PREPARATION AND EVALUATION OF MICROEMULSION CONTAINING ANTIHYPERTENSIVE DRUG by Yadav, Vishal et al.
 
 




VISHAL YADAV, PRAKASH JADHAV, KISHOR KANASE, ANJALI BODHE*
Arvind Gavali College of Pharmacy, Jaitapur, Satara 415004, India 
Email: anjali.bodheagcop@gmail.com  
, SHAILAJA DOMBE 
Received: 19 May 2018, Revised and Accepted: 05 Jul 2018 
ABSTRACT 
Objective: The aim of the present study was to design novel drug delivery system containing ramipril microemulsion. Ramipril is an 
antihypertensive drug having very low aqueous solubility and bioavailability. Ramipril microemulsion could be used as a possible alternative to the 
traditional oral formulation to improve dissolution rate and hence its bioavailability with avoidance of the first-pass metabolism. 
Methods: The microemulsion existence region was determined by constructing pseudoternary phase diagram and prepared by using four 
components orange oil, tween 80 as a surfactant, propylene glycol as co-surfactant and distilled water as the aqueous phase. The water titration 
method was employed for its determination. All formulated microemulsion were subjected for visual inspection, centrifugation and stability test. 
The all stable formulations were selected for further study. 
The optimized microemulsion formulation B-9 was subjected for various evaluation parameters such as, visual inspection, stability studies, pH, 
viscosity measurements, electrical conductivity, content uniformity and dye solubility test.  
Results: Results revealed that construction of phase diagram and use of phase titration method was a suitable technique for the preparation of 
microemulsion as most of the formulations were transparent. It was found that the best microemulsion result was found for ratio 2:1. The results of 
stress tests conclude that the optimized formulation was both physically and chemically stable for 8 mo. Also, The Fourier transform infrared (FTIR) 
radiation measurement and Differential scanning calorimetry (DSC) of optimized formulation indicate the compatibility of ramipril with orange oil, 
surfactant-tween 80 and cosurfactant-propylene glycol. From electrical conductivity 0.283 σ and staining test the prepared optimized formulation 
B-9 was found to be o/w type of microemulsion. The optimized B-9 formulation showed good viscosity 13.52±0.01cps and pH 3.21±0.02 with 
highest drug content uniformity was found to be 84.98±0.02 %.  
Conclusion: In the present study a satisfactory attempt was made to formulate a novel o/w microemulsion of ramipril which improves the 
gastrointestinal absorption by raising its water solubility and hence oral bioavailability is also enhanced.  
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Drug solubility enhancement is one of the most important challenges 
in the field of pharmaceutics. Nearly 40% of all new pharmacologically 
potent molecules show poor aqueous solubility, leading to their low 
effective concentration in biofluids and therefore poor bioavailability. 
Many studies have been focused on enhancing the solubility of poorly 
water-soluble drugs and improving bioavailability to administer them 
through oral route resulting in increasing their clinical efficacy. One of 
the most popular approach is the incorporation of the active lipophilic 
component into inert lipid vehicles, such as oils, surfactant 
dispersions, self-emulsifying formulations, emulsions, and liposomes. 
Microemulsion allows the incorporation of hydrophilic as well as 
lipophilic compound depending on their internal structure. These 
aggregates have been described as reservoir systems, which allow 
slow release of drugs, thus providing prolonged effects and avoiding 
high concentration in the blood [1-3]. 
Microemulsions (MEs) are isotropic, thermodynamically stable, 
transparent (or translucent) systems of oil, water, and surfactant, 
frequently in combination with a co-surfactant with a droplet size 
usually in the range of 10-100 nm. These homogeneous systems, which 
can be prepared over a wide range of surfactant concentration and oil to 
water ratio, are all fluids of low viscosity. A microemulsion as drug 
delivery tool show favorable properties like thermodynamic stability 
(long shelf-life), easy formation (zero interfacial tension and almost 
spontaneous formation), optical isotropy, ability to be sterilized by 
filtration, high surface area (high solubilization capacity) and very small 
droplet size. The small droplets also provide better adherence to 
membranes and transport drug molecules in a controlled fashion [4]. 
MEs have been suggested to positively influence drug absorption in 
a number of ways, such as protecting the incorporated drugs from 
oxidation and enzymatic degradation and enhancing membrane 
permeability and lymphatic transport. Lymphatic transport is 
thought to make a significant contribution to absorption from the 
intestine as it circumvents the hepatic first-pass effect. 
The primary advantage of intestinal lymphatic drug transport is that 
drugs absorbed via the intestinal lymphatic system are protected 
from hepatic first-pass metabolism because the mesenteric lymph, 
in contrast to the portal blood, enters the systemic circulation 
directly without first passing through the liver. Therefore, intestinal 
lymphatic transport might have a substantial beneficial impact on 
drug bioavailability after oral administration, especially for drugs 
that are deactivated by hepatic metabolism. Mechanisms of 
microemulsion useful for enhancing the oral bioavailability, the 
comparison between oil-in-water and water-in-oil microemulsions 
using the single-pass intestinal perfusion [5]. 
We worked on drug, ramipril [(2S, 3aS, 6aS)-1[(S)-N-[(S)-carboxy-3-
phenyl propyl] alanylocta-hydrocyclopenta [b] pyrrole-2-carboxylic 
acid, 1-ethyl ester], an effective inhibitor of angiotensin-converting 
enzyme (ACE), prevents the conversion of AT I (Angiotensin I) to AT 
II (Angiotensin II). It is effective in patients suffering from 
hypertension, myocardial infarction, stroke, congestive heart failure 
and also acts as an antiproteinuric agent in children with chronic 
renal failure. Being a highly lipophilic compound, it has an oral 
bioavailability of 28–30% due to its poor aqueous solubility. This 
may result in dissolution related problem and low absorption and 
therefore the efficacy may be greatly reduced. 
Due to the drawbacks stated above such as low solubility and low oral-
bioavailability, we tried to design an essential oil based microemulsion 
system as a drug delivery vehicle. A microemulsion typically consists 
of oil, surfactant and water in required and optimized proportions. 
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These are clear, stable and isotropic mixtures. Microemulsion can be 
formed upon simple mixing of the components and do not require high 
energy conditions. The advantages of using a microemulsion are 
spontaneous formation, ease of manufacturing and scale-up, 
thermodynamic stability, improved drug solubilization of hydrophobic 
drugs and bioavailability [6]. 
In the present study, ramipril microemulsion was prepared using 
orange oil, tween 80 as surfactant, propylene glycol as co-surfactant 
and distilled water with the help of phase titration method. 
MATERIALS AND METHODS 
Materials 
Ramipril was procured from Yarrow Chem Products, Mumbai. 
Orange oil and propylene glycol were obtained from Vishal Chem, 
Mumbai. Tween 80 was purchased from SD Lab Chemical Centre, 
Mumbai. All other reagents used were of analytical grade. 
Microemulsions are prepared by the Phase Titration Method and can 
be portrayed with the help of a phase diagram. 
 
Table 1: List of instruments 
S. No. Name of the instruments Manufacturer 
1  Digital pH meter Digital Potentiometer Model EQ-601 Equip-tronics 
2  Laboratory centrifuge Remi Lab-Speed 3500 
3  Sonicator Wensor-Digital Ultrasonic Cleaner WUC-1.8 L 
4 Brookfield viscometer DV-E Brookfield Viscometer Model-LVDVE Mfg. Brookfield Engineering Lab 
5 Conductometer Digital Conductivity meter Model–ME-976 C from Max Electronics 
6  Digital pan balance Shimadzu Corporation Model-ATX224 
7  UV spectrophotometer Dynamica DB-20 Model-Halo DB-20 
8 Differential scanning calorimeter  PerkinElmer 4000,PYRIS Version-11.1.0.0488, 2009, PerkinElmer, Inc.  
9 Infrared spectrophotometer Shimadzu Corporation  
10 Orbital shaking incubator Remi Electro-Technic Limited Model-RIS-24 BL 
11 Incubator Biotechnics India 
 
Method 
The microemulsion of respective composition, as shown in the table 
2, 3 and 4 were devised using four component orange oil as oil 
phase, tween 80 as a surfactant, propylene glycol as co-surfactant, 
and distilled water as the aqueous phase. Batches were designed for 
different surfactant–cosurfactant ratios (S/Cos ratio). In the present 
study, three S/Cos ratios, 1:1, 2:1, 3:1, were tried. 
The microemulsion containing ramipril were prepared by phase 
titration method constructing the phase diagram. Pseudoternary phase 
diagrams were constructed to investigate the effect of surfactant to co-
surfactant ratio on the area of microemulsion existence region. 
Pseudoternary phase diagrams of oil, water, and surfactant/co-
surfactants (S/Cos) mixtures are constructed at fixed surfactant/ 
cosurfactant weight ratios. Phase diagrams are obtained by mixing 
of the ingredients, which shall be pre-weighed into glass vials and 
titrated with water and stirred well at room temperature. 
Formation of the monophasic/biphasic system is confirmed by 
visual inspection. In case turbidity appears followed by a phase 
separation, the samples shall be considered as biphasic. In case 
monophasic, clear and transparent mixtures are visualized after 
stirring; the samples shall be marked as points in the phase 
diagram. The area covered by these points is considered as the 
microemulsion region of existence [6]. 
 
Table 2: Composition of ramipril micro emulsions S/Cos ratio (1:1) 
S. No.  Ramipril (mg) Smix Oil Water 
A-1 500 40 40 20 
A-2 500 42 28 30 
A-3 500 40 20 40 
A-4 500 37 15 48 
A-5 500 39 13 48 
A-6 500 38 11 51 
A-7 500 32 8 60 
A-8 500 31 7 62 
A-9 500 30 6 64 
  
Table 3: Composition of ramipril microemulsion S/Cos ratio (2:1) 
S. No. Ramipril (mg) Smix Oil Water 
B-1 500 40 40 20 
B-2 500 45 30 25 
B-3 500 44 22 34 
B-4 500 40 16 44 
B-5 500 42 14 44 
B-6 500 38 11 51 
B-7 500 32 8 60 
B-8 500 31 7 62 
B-9 500 25 5 70 
 
Phase behavior investigations of this system demonstrated the 
suitable approach to determine the water phase, oil phase, 
surfactant and co-surfactant concentration for which transparent, 
one phase, low viscous system form. The effect of three different 
surfactant co-surfactant ratios 1:1, 2:1 and 3:1 was determined in 
this system of orange oil/tween-80/propylene glycol and water. 
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Table 4: Composition of ramipril microemulsion S/Cos ratio (3:1) 
S. No. Ramipril (mg) Smix Oil Water 
C-1 500 36 36 28 
C-2 500 39 26 35 
C-3 500 38 19 43 
C-4 500 40 16 44 
C-5 500 42 14 44 
C-6 500 42 12 46 
C-7 500 36 9 55 
C-8 500 36 8 56 
C-9 500 35 7 58 
 
Evaluation of ramipril microemulsion 
Saturation solubility of ramipril in oil, surfactant and co-surfactant 
To determine saturation solubility of ramipril shake flask method is 
used. An excess amount of ramipril was added to each cap vial 
containing 2 ml of the vehicles. After sealing, the mixture was 
vortexes at maximum speed for 10 min in order to facilitate proper 
mixing of ramipril with the vehicles. Mixtures were then shaken in 
shaker maintained at room temperature until equilibrium (48 h). 
After 24 h the vial observed for the residue of drug, and again the 
excess amount of drug was added into the vial showing no residue 
and kept for shaking for an additional 24 h. Then mixtures were then 
centrifuged at 3000 rpm for 10 min. The supernatants were 
collected into glass vials, and analysis was carried out with UV-
visible spectroscopy to find the concentration of drug [8]. 
Preparation of microemulsion 
The microemulsion existence region was determined by 
constructing pseudoternary phase diagram. Phase diagrams are 
obtained by mixing of the ingredients, which shall be pre-weighed 
into glass vials and titrated with distilled water and stirred well at 
room temperature. Formation of the monophasic/biphasic system is 
confirmed by visual inspection. In case turbidity appears followed 
by phase separation, the samples shall be considered as biphasic. In 
the case of the monophasic system, the clear and transparent 
mixtures are visualized after stirring; the samples shall be marked 
as microemulsion formulations [7, 15, and 17]. 
Visual inspection 
Visual inspection was made after each addition of water to the oil 
and surfactant or surfactant and co-surfactant mixture. The samples 
were identified as microemulsion, emulsion or gel formation by 
visual observation [7, 8]. 
Thermodynamic stability 
To overcome the problem of metastable formulation, thermo-
dynamic stability tests were performed [8, 9]. 
a) Centrifugation 
The formulation was centrifuged at 3500 rpm for 30 min to ensure 
physical stability.  
b) Stress test 
These tests were done to optimize the best microemulsion 
formulation under extreme conditions. Stress was carried out at 4 °C 
and 45 °C for 48 h each for a period of six cycles, followed by 25 °C 
and 21 °C for 48 h for about three cycles. The samples were checked 
for coalescence, cracking or phase separation. 
Measurement of pH 
The pH values of the optimized formulation were measured by 
immersing the electrode directly into the dispersion using a calibrated 
pH meter (Digital Potentiometer Model EQ-601 Equip-Tronics) [7]. 
Viscosity measurements 
The viscosity of the optimized formulation was determined as such 
without dilution using Brookfield Viscometer (DV-E Brookfield 
Viscometer Model-LVDVE). 
Brookfield Viscometer consist of a cup, which is stationary and a 
spindle which is rotating. Different sized rotating spindles are used 
and immersed in test material. For liquids with low viscosity, large 
size spindles (large diameter and surface area) are used while for 
higher viscosity liquids small spindles (small diameter and surface 
area) are used. Rotate the spindle in the microemulsion till we get a 
constant dial reading on the display of the viscometer. This 
procedure is repeated three times for reproducible results [7, 18]. 
Drug content estimation 
Microemulsion containing 100 mg drug was dissolved in 100 ml 
0.1N HCL taken in volumetric flask. Then the solvent was filtered, 1 
ml was taken in 50 ml volumetric solution and diluted up to the 
mark with 0.1N HCL and analyzed spectrometrically at 221 nm. The 
concentration of ramipril in mg/ml was obtained by using standard 
calibration curve of the drug. Drug content studies were carried out 
in triplicate for each formulation batch [8, 18]. 
Measurement of electrical conductivity 
The conductivity measurements help in determining whether the 
microemulsion system formed is oil-continuous or water-
continuous. The solubilization of water phase in the selected oily 
mixture was monitored quantitatively by measuring the electrical 
conductivity (σ). The conductivity (σ) of the formulated samples was 
measured using a conductivity meter (Digital Conductivity meter 
Model–ME-976 C from Max Electronics) [8]. 
Staining test/dye-solubility test 
Water soluble dye, methylene blue solution of 10 μl was added to 
the emulsion. If the continuous phase is water (o/w emulsion), the 
dye will dissolve uniformly throughout the system. If the continuous 
phase is oil (w/o emulsion), the dye will remain as cluster on the 
surface of the system [9]. 
Differential scanning calorimetry (DSC) 
Thermal analysis is an important evaluation technique to find any 
possible interaction between the drug and excipients. Such interaction 
can be identified by any change in thermogram. About 1 mg of the 
sample was sealed in the aluminum pan and heated at the rate of 10 
°C/min, covering a temperature range of 30 °C to 300 °C under 
nitrogen atmosphere of flow rate 20 ml/min and DSC thermogram 
(PerkinElmer 4000, PYRIS Version-11.1.0.0488, 2009, PerkinElmer, 
Inc.) for pure drug and prepared microemulsion was obtained [16]. 
FTIR spectroscopy 
It was determined by Fourier Transform Infrared Spectro-
photometer (FTIR, Simadzu Corporation). The sample was scanned 
over wavelength region of 4000 to 400 cm-1 at a resolution of 4 cm-1
RESULTS AND DISCUSSION 
 
by dispersing sample in KBr and compressing into the disc by 
applying pressure of 5 tons for 5 min in a hydraulic press. The pellet 
was placed in light path and the spectrum was obtained [14]. 
Determination of solubility of ramipril in different oils, 
surfactant and co-surfactant 
For determination of solubility of ramipril, isopropyl myristate, 
orange oil, soybean oil, groundnut oil and coconut oil were used as 
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oil phase, tween-60, tween-80 and sodium lauryl sulphate (SLS) 
were used as surfactants and polyethylene glycol-400 (PEG 400), 
polyethylene glycol-200 (PEG 200) and propylene glycol (PG) were 
used as co-surfactants. Each ingredient is selected based on the 
higher solubility of ramipril in oil, surfactant and co-surfactant. Oil 
and surfactant were selected on the basis of ease and spontaneous 
formation of an emulsion. Cosurfactant should provide very low 
interfacial tensions required for the formation of the microemulsion. 
Required hydrophilic-lipophilic balance (HLB) for the formation of 
o/w (oil in water) microemulsion was also considered while 
selecting oil, surfactant and co-surfactant. 
The solubility of ramipril is more in orange oil, surfactant tween 80 
and cosurfactant propylene glycol. The solubility of ramipril in 
different oils and surfactant, cosurfactant solutions are shown in 
table 5, 6 and 7 respectively. 
 
Table 5: Solubility study of ramipril in oils 





Isopropyl myristate 0.381±0.01 
Orange oil  85.283±2.26 
Soybean oil  0.092±0.01 
Groundnut oil  0.104±0.01 
Coconut oil  0.085±0.01 
 (mean±SD; n=3) 
 
To maintain the drug stable in its lipophilic environment oil system plays 
an important role. Thus different oil was chosen for our work and their 
solubility shown in table 5. It was found that the solubility of ramipril 
was higher in orange oil (85.283±2.26) as compared to other oils and so 
orange oil was the best vehicle for preparation of microemulsion. 
Tween 80 is nonionic surfactants with high hydrophilic-lipophilic 
balance (values) which is a good guide for mixing water and oil into 
the microemulsion. As shown in table 6 tween 80 was selected as a 
surfactant due to its higher drug solubilizing capacity and 
biocompatibility than other surfactants. 
 
Table 6: Solubility study of ramipril in surfactants 
S. No. Phase type  Excipient Solubility (mg/ml) 
1 
 
 Surfactants  Tween 80 6.428±0.02 
Tween 60 0.206±0.01 
 SLS 0.445±0.03 
 (mean±SD; n=3) 
 
Table 7: Solubility study of ramipril in co-surfactants 
S. No. Phase type Excipient Solubility (mg/ml) 
1 
 
 Co-surfactants PEG 400 0.231±0.01 
PEG 200  0.142±0.01 
Propylene glycol 7.705±0.02 
 (mean±SD; n=3) 
 
Co-surfactants increase the flexibility of surfactant film around 
the microemulsion droplet. The role of co-surfactant is to 
overcome the repulsive forces of similar phases and fluidity of 
oil and water to increase the permeability of two phases to form 
a microemulsion. It was observed that the solubility of ramipril 
was higher in propylene glycol (7.705±0.02) as compared to 
other co-surfactants. So propylene glycol was selected as co-
surfactant due to its ability to form clear and stable 
microemulsion formulation. 
Preparation of microemulsion 
Microemulsion was prepared by dissolving ramipril in orange oil. To this 
optimized ratio of surfactant-tween 80 and co-surfactant-propylene 
glycol was mixed followed by gentle mixing with distilled water. 
 
  
S/Cos ratio 1:1     S/Cos ratio 2:1 
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S/Cos ratio 3:1 
Fig. 1: Pseudoternary phase diagrams at different S/Cos ratio 
 
A pseudoternary phase diagram of investigated quaternary system 
orange oil, tween 80, propylene glycol, water is presented in Fig.1. 
The formation of a microemulsion system (the shaded area) was 
observed at room temperature. From the pseudo phase diagrams, it 
was concluded that the highest microemulsion zone was obtained 
for the ratio of 3:1. It was observed that the microemulsion zone 
increased with increasing S/Cos ratio. There was the very slight 
difference in microemulsion zone obtained for S/Cos ratio 3:1 and 
2:1. The phase study revealed that the maximum proportion of 
water is incorporated in the microemulsion system when the S/Cos 
ratio was 2:1. Increased content of water and decreased the content 
of surfactant-co-surfactant and oil provide a greater opportunity for 
the solubilization of ramipril which is an added advantage for less 
viscous and transparent micro emulsion. 
  
 
Fig. 2: Microemulsion preparation S/Cos ratio 2:1 
 
The developed microemulsion containing ramipril, orange oil, tween 
80, propylene glycol and water was found to be transparent at 
increased water content and decreased surfactant and oil content. At 
first, the microemulsion showed milky appearance but at increased 
water content and optimum S/Cos ratio 2:1 it showed transparent 
flowable microemulsion. 
Visual inspection 
The samples were identified as microemulsions when they appear as 
transparent/translucent and easily flowable liquid. The samples 




Fig. 3: Difference between emulsion and microemulsion formulations 
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In fig. 3 first two formulations were found to be milky and turbid so 
considered as emulsions with two phases. And the last one that is 
the third formulation was transparent and easily flowable liquid so 
considered as microemulsion with only one phase. 
Thermodynamic stability 
Thermodynamic stability tests were performed by 
a) Centrifugation 
Formulations A-1 to A-3, B-4 to B-6 and C-1 to C-3 clearly separated 
into two phases after centrifugation, which was milky, white in 
appearance considered as emulsions and rejected. The 
centrifugation tests revealed that microemulsion formulations A-4 
to A-9, B-1 to B-3, B-7 to B-9 and C-4 to C-9 were remained 
homogenous without any phase separation throughout the test 
indicates good physical stability and taken for further study. 
b) Stress test  
As per following data, only eleven formulations passed through 
different stress conditions as shown in table 8. Formulation A-4, A-5, 
A-8 and A-9 were passed the centrifugation and stress test. 
Microemulsion formulations B-3, B-8 and B-9 showed good results 
with better stability. Similarly, microemulsion formulations C-5, C-6, 
C-8 and C-9 were stable in all temperature conditions. From all these 
stable formulations the microemulsions containing a high content of 
surfactant-co-surfactant were rejected. 
  
Table 8: Observations of stress tests 
Formulations Observations of stress tests 
Centrifugation 25 to 30 °C 45 °C 4 °C 
A-4         
A-5         
A-6        x 
A-7      x  x 
A-8         
A-9         
B-1    x  x   
B-2    x  x   
B-3         
B-7        x 
B-8         
B-9         
C-4      x   
C-5         
C-6         
C-7    x  x   
C-8         
C-9         
 
Thus A-9, B-9 and C-9 formulation serves as the best microemulsion 
formulations with no phase separation, creaming or flocculation and 
was taken for further characterization. The results of the stress tests 
concluded that the formulations were both physically and 
chemically stable. The formulations which showed the very high 
content of surfactant were rejected. 
 
Table 9: Viscosity, pH and content uniformity 
S. No. Formulation Viscosity(cps) pH Content uniformity 
1 A-9 16.62±0.02 3.48±0.01 72.48±0.02 
2 B-9  13.52±0.01 3.21±0.02 84.98±0.02 
3  C-9  18.23±0.01 3.63±0.01 69.52±0.01 
 (mean±SD; n=3) 
 
Evaluation parameters of formulations 
The physicochemical characteristics of developed microemulsion 
appear in table 9. From the above result, it was found that 
formulations showed increased pH with increased S/Cos ratio. It 
was observed that formulation B-9 showed large content uniformity 
(84.98%) having viscosity 13.52cps and pH 3.21 than other two 
formulations A-9 and C-9. B-9 formulation showed more water 
quantity with less surfactant having large microemulsion region. So 
formulation B-9 is considered as an optimized microemulsion.  
Measurement of electrical conductivity 
The conductivity of the optimized microemulsion (B-9) as determined 
by the conductivity meter was found to be 0.283 σ. From electro 
conductivity study it can be concluded that the system is of o/w type. 
Staining test/dye-solubility test 
Water soluble dye, methylene blue solution was added to optimized 
microemulsion (B-9), the dye will dissolve uniformly throughout the 
system, so the continuous phase was water. Hence the optimized 
formulation B-9 was found to be o/w type of microemulsion is 
shown in fig. 4. 
 
 
Fig. 4: Staining of optimized microemulsion (B-9)
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Drug-excipient interaction study by DSC thermogram 
 
Fig. 5: DSC of pure ramipril 
 
 
Fig. 6: DSC of optimized formulation B-9 
 
Thermograph of ramipril is shown in fig. 5. Melting transition of ramipril 
was observed from 108.01 °C (Onset) to 112.98 °C (Endset). Sharp 
melting transition of ramipril was observed at 111.09 °C. In the 
optimized formulation fig. 6, drug and excipients melting endotherm was 
observed from 120.33 °C (Onset) to 122.13 °C (Endset). Sharp melting 
transition of Ramipril was observed at 120.44 °C. In case of optimized 
formulation, B-9 drug peak is shifted to slightly lower temperature and 
decreases the intensity of peak which may be due to baseline shifting. 
There was no much difference in the melting point of the drug in 
optimized B-9 microemulsion thermographs, shown in fig. 7. 
 
 
Fig. 7: Comparison of pure drug and optimized formulation B-9 
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Drug excipients interaction by IR spectrum 
 
Fig. 8: FTIR of ramipril 
 
 
Fig. 9: FTIR of optimized microemulsion B-9 
 
FTIR studies revealed that there was no appearance of any new peak 
and disappearance of existing peaks, which indicated that there was 
no chemical interaction between the drug and excipients used. The 
characteristic–NH and–OH stretching at 3278.99 cm-1,–CH aromatic 
stretching at 2929.87 cm-1,–CH aliphatic stretching at 1741.72 cm-1,–
C=O of acid at–C=O of acid at 1651.07 cm-1ester group at 1498.69 
and 1450.47 cm-1
CONCLUSION 
 were identified in all the spectra. All the 
characteristic peaks of Ramipril were observed in the IR spectra of 
physical drug and optimized formulation B-9 during the 
investigation of compatibility study which is shown in fig. 9. Hence 
IR spectroscopy results showed that the drug was compatible with 
selected excipients and was stable in optimized B-9 microemulsion. 
The developed microemulsion containing orange oil was found to be a 
suitable vehicle to formulate ramipril microemulsion. Microemulsion 
containing orange oil, tween 80, propylene glycol and water provide a 
useful dosage form for poorly water-soluble drug ramipril. By the 
construction of the phase diagram, it was found that best 
microemulsion results were found for ratio 2:1. In the present study 
optimized formulation, B-9 was transparent and easily flowable liquid. 
The results of stress tests concluded that the optimized formulation 
was physically and chemically stable for 8 mo. From electrical 
conductivity (0.283 μS/cm) and staining test, it was found that the 
optimized formulation B-9 was o/w type of microemulsion having 
content uniformity 84.98%, viscosity 13.52cps and pH 3.21. Also, FTIR 
and DSC study of optimized formulation indicate the compatibility of 
ramipril with orange oil, surfactant-tween 80 and cosurfactant-
propylene glycol. Thus the study confirmed that microemulsion 
formulation can be used as a possible alternative to the conventional 
oral formulation of ramipril to improve its solubility and oral 
absorption. It was concluded that the high content of water gives us 
o/w microemulsion with low viscosity having more absorption inside 
the body and lower content of surfactant reduces the side effects. 
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